中文产业新闻评分60Chinese source
阿斯利康PD-1/CTLA-4双抗Volrustomig一线NSCLC三期临床失败
阿斯利康：PD-1/CTLA-4双抗一线治疗NSCLC三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
阿斯利康：PD-1/CTLA-4双抗一线治疗NSCLC三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.